TRANSCENTA-B_Providing professional financial news and data related to TRANSCENTA-B, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

TRANSCENTA-B (06628.HK): Proposes disposal of CDMO assets for RMB 190 million to a WuXi Biologics subsidiary, focusing on innovative drug R&D as core business

Tags：

TRANSCENTA-B 06628.HK

2026-08-07

ETF
Premia China STAR50 ETF (03151.HK) Gains 2.08% Intraday, NAV Per Unit at HK$12.026
ETF
Samsung S&P Gsci Crude Oil Er Futures Etf (03175.HK) Rises 3.51% Intraday at HK$9.59
Finance
Linmon Media Limited (09857.HK): Expected H1 Net Profit to Surge Around 77.7% to 255.4% Year-on-Year
Finance
Nuobikan Artificial Intelligence Technology (02635.HK): Signs RMB50.8 Million Software Sales Contract
Finance
Creality 3D Technology (03388.HK): Expected Loss of RMB53 Million–RMB63 Million for First Half
Finance
C C Land Holdings (01224.HK): Expected to Swing to Profit in First Half, Net Profit Around HK$30 Million
Finance
Sino Biopharmaceutical (01177.HK): Second-Generation Flurbiprofen Patch Approved for Marketing
Research
Autonomous Driving Concept Stocks Watch | RoboSense (02498.HK) Weakens in Afternoon Session; L2 Smart Driving Players May Rebound on Improved Industry Beta Expectations
ETF
Tracker Fund Of Hong Kong (02800.HK) Falls 1.82% Intraday, AUM Stands at HK$141.845 Billion
ETF
iShares Core MSCI AC Asia ex Japan Index ETF (03010.HK) Falls 1.59% Intraday, Turnover Hits HK$20.3242 Million

Scan QR Code

Download App